Detalhe da pesquisa
1.
Monovalent SARS-CoV-2 mRNA Vaccine Does not Boost Omicron-Specific Immune Response in Diabetic and Control Pediatric Patients.
J Infect Dis
; 229(4): 1059-1067, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624979